Viral infections in lung transplant recipients

Pali Dedhiya Shah, John F. McDyer

Research output: Contribution to journalArticle

Abstract

Viral infections, including -herpes viruses and community respiratory viruses, are frequent pathogens in lung transplant recipients. These pathogens have become increasingly recognized as having a significant role in long-term outcomes of lung transplantation, which has been limited by the frequent development of infections, and chronic allograft dysfunction. Community respiratory viruses, such as influenza and respiratory syncytial virus have been associated with both acute rejection and chronic allograft dysfunction, particularly if early treatment was not administered. -herpes viruses, particularly cytomegalovirus (CMV), have long been associated with increased mortality in lung transplant recipients, although the advent of effective antiviral strategies has led to improved morbidity and mortality. Because these pathogens have been associated with altered immune responses against the allograft, a better understanding of immunopathogenesis of viral infections may lead to a broader approach to limit the morbidity from these pathogens.

Original languageEnglish (US)
Pages (from-to)243-254
Number of pages12
JournalSeminars in Respiratory and Critical Care Medicine
Volume31
Issue number2
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Virus Diseases
Viruses
Allografts
Lung
Morbidity
Respiratory Syncytial Viruses
Lung Transplantation
Mortality
Cytomegalovirus
Human Influenza
Antiviral Agents
Transplant Recipients
Infection
Therapeutics

Keywords

  • Cytomegalovirus
  • Lung transplantation
  • Respiratory virus

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Viral infections in lung transplant recipients. / Shah, Pali Dedhiya; McDyer, John F.

In: Seminars in Respiratory and Critical Care Medicine, Vol. 31, No. 2, 2010, p. 243-254.

Research output: Contribution to journalArticle

@article{ad4eec20ef1c4d08bfe2e749e8643f06,
title = "Viral infections in lung transplant recipients",
abstract = "Viral infections, including -herpes viruses and community respiratory viruses, are frequent pathogens in lung transplant recipients. These pathogens have become increasingly recognized as having a significant role in long-term outcomes of lung transplantation, which has been limited by the frequent development of infections, and chronic allograft dysfunction. Community respiratory viruses, such as influenza and respiratory syncytial virus have been associated with both acute rejection and chronic allograft dysfunction, particularly if early treatment was not administered. -herpes viruses, particularly cytomegalovirus (CMV), have long been associated with increased mortality in lung transplant recipients, although the advent of effective antiviral strategies has led to improved morbidity and mortality. Because these pathogens have been associated with altered immune responses against the allograft, a better understanding of immunopathogenesis of viral infections may lead to a broader approach to limit the morbidity from these pathogens.",
keywords = "Cytomegalovirus, Lung transplantation, Respiratory virus",
author = "Shah, {Pali Dedhiya} and McDyer, {John F.}",
year = "2010",
doi = "10.1055/s-0030-1249120",
language = "English (US)",
volume = "31",
pages = "243--254",
journal = "Seminars in Respiratory and Critical Care Medicine",
issn = "1069-3424",
publisher = "Thieme Medical Publishers",
number = "2",

}

TY - JOUR

T1 - Viral infections in lung transplant recipients

AU - Shah, Pali Dedhiya

AU - McDyer, John F.

PY - 2010

Y1 - 2010

N2 - Viral infections, including -herpes viruses and community respiratory viruses, are frequent pathogens in lung transplant recipients. These pathogens have become increasingly recognized as having a significant role in long-term outcomes of lung transplantation, which has been limited by the frequent development of infections, and chronic allograft dysfunction. Community respiratory viruses, such as influenza and respiratory syncytial virus have been associated with both acute rejection and chronic allograft dysfunction, particularly if early treatment was not administered. -herpes viruses, particularly cytomegalovirus (CMV), have long been associated with increased mortality in lung transplant recipients, although the advent of effective antiviral strategies has led to improved morbidity and mortality. Because these pathogens have been associated with altered immune responses against the allograft, a better understanding of immunopathogenesis of viral infections may lead to a broader approach to limit the morbidity from these pathogens.

AB - Viral infections, including -herpes viruses and community respiratory viruses, are frequent pathogens in lung transplant recipients. These pathogens have become increasingly recognized as having a significant role in long-term outcomes of lung transplantation, which has been limited by the frequent development of infections, and chronic allograft dysfunction. Community respiratory viruses, such as influenza and respiratory syncytial virus have been associated with both acute rejection and chronic allograft dysfunction, particularly if early treatment was not administered. -herpes viruses, particularly cytomegalovirus (CMV), have long been associated with increased mortality in lung transplant recipients, although the advent of effective antiviral strategies has led to improved morbidity and mortality. Because these pathogens have been associated with altered immune responses against the allograft, a better understanding of immunopathogenesis of viral infections may lead to a broader approach to limit the morbidity from these pathogens.

KW - Cytomegalovirus

KW - Lung transplantation

KW - Respiratory virus

UR - http://www.scopus.com/inward/record.url?scp=77950534954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950534954&partnerID=8YFLogxK

U2 - 10.1055/s-0030-1249120

DO - 10.1055/s-0030-1249120

M3 - Article

C2 - 20354936

AN - SCOPUS:77950534954

VL - 31

SP - 243

EP - 254

JO - Seminars in Respiratory and Critical Care Medicine

JF - Seminars in Respiratory and Critical Care Medicine

SN - 1069-3424

IS - 2

ER -